Jianmin Group announced that in the first half of 2026, it achieved operating income of 1,611 billion yuan, a year-on-year decrease of 10.72%; net profit attributable to shareholders of listed companies was 177 million yuan, a year-on-year decrease of 19.68%; and net profit after deducting non-recurring profit and loss of 153 million yuan, a year-on-year decrease of 21.48%. The decline in revenue was mainly due to the decline in revenue from the pharmaceutical industry and the pharmaceutical business by 9.24% and 13.31% respectively. The decline in net profit was mainly due to a decrease in investment income of joint ventures. Net cash flow from operating activities was 120 million yuan, up 116.27% year on year, and basic earnings per share were 1.17 yuan, down 19.86% year on year. There were no profit distribution plans for the reporting period.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.